GL1X · GenesisL1 explorer

Research workbench

Discovery of potent mcl-1 inhibitors using fragment-based methods and structure-based design

Analyse Discovery of potent mcl-1 inhibitors using fragment-based methods and… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4HW4
Type
protein
Length
327 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Induced myeloid leukemia cell differentiation protein mcl- 1; Mcl-1 BH3 peptide
UniProt
Q07820
Ligands
ACE, NH2

Structure

x-ray diffraction · 3 distinct chains · 81% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInduced myeloid leukemia cell differentiation protein mcl- 1protein15479% helix, 0% strandQ07820
BInduced myeloid leukemia cell differentiation protein mcl- 1protein14184% helix, 0% strandQ07820
C, DMcl-1 BH3 peptideprotein1688% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · 2 copies · chains A, C, B, D
  • NH2 · Amino group · ion · 2 copies · chains A, C, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

3 interfaces between chains.

  • B–D · 796 Ų buried · 7 hydrogen bonds · protein-protein
  • A–C · 791 Ų buried · 7 hydrogen bonds · protein-protein
  • A–B · 18 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 4HW4 · Discovery of potent Mcl-1 inhibitors using fragment-based methods and structure-based… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.